Page 43 - Roche Diagnostics News Today

M: 07584 146035 E:  mediaoffice@kingsfund.org.uk  (monitored 9am-5pm, Monday to Friday - please call the mobile number above outside of these hours) 

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

Report Highlights Unmet Medical Needs of Patients Facing Unintentional Weight Loss, Muscle Weakness, and Fatigue...

In Roche Diagnostics Corp. v. Meso Scale Diagnostics, LLC, No. 21-1609, -1633 (Fed. Cir. April 8, 2022), the majority opinion of the Court of Appeals for the Federal Circuit...

/PRNewswire/ -- Aware Recovery Care, Inc. ("Aware" or "the Company") announced today that it has appointed Jennifer Lohse J.D., CHC as Chief Legal Officer, Roy...

In a population-based cohort study in Scotland, Abiodun Adanikin and colleagues study the association of birthweight centiles and motor, communication, and social developmental concerns identified at ages 2 to 3.5 years of age.

In a population-based cohort study in Scotland, Abiodun Adanikin and colleagues study the association of birthweight centiles and motor, communication, and social developmental concerns identified at ages 2 to 3.5 years of age.

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers from the University of Minnesota Medical School aided in the discovery that insulin glargine and liraglutide performed best.

A bankruptcy trustee has filed a lawsuit alleging that Baker & Hostetler helped a client commit “blatant insurance fraud

Author and Educator Stephen R Covey said, “If you don’t have confidence in the diagnosis, you won’t have confidence in the prescription.”